Our Funding

Grant Support

  • NIH/NIAID: Public HIV Drug Resistance Database 1R01AI68581 (2006 - 2018)
  • Gilead Sciences: HIV Drug Resistance Database (2015 - 2016)
  • Bristol Myers Squibb Transmitted Antiretroviral Resistance 2003 to 2012. Effect of Deep Sequencing on Prevalence of Drug Resistance Mutations and Response to First-Line Therapy (2014 - 2015)
  • Merck Transmitted Antiretroviral Resistance and Low-Abundance Drug Resistance Mutations: Implications for Raltegravir plus Truvada Therapy (2014 - 2015)
  • Bill & Melinda Gates Foundation: Consensus HIV-1 Drug Resistance Mutations for Point-Of-Care (POC) Genotypic Resistance Tests (2013 - 2014)
  • NIH/NIGMS: Targeting Ensembles of Drug Resistant Protease Variants Project: Conformational Flexibility of HIV-1 Protease in vivo. PO1 (2002 - 2011)
  • Gilead Sciences: Hepatitis B Minority Variants in Patients Treated with Lamivudine and/or Interferon (2009 - 2011)
  • Merck: Raltegravir: Clinical Use, Virological Response, and Drug Resistance in a Large Clinic-Based Population (2009 - 2010)
  • Hoffman La Roche Ultra-Deep Sequencing to Detect Resistance to Small Molecule Hepatitis C Inhibitors (2009 - 2011)
  • California HIV Research Program: Clinical Significance of Minority HIV-1 Variants (2009 - 2011)
  • NIH/Blood Systems Research Institute (R01 subcontract): Metagenomic Analysis of the Human Virome (2007 - 2011)
  • NIH/NIAID 1R01 AI46148-01: Identification of Multidrug-Resistant HIV-1 Isolates (1998 - 2008)
  • California University-Wide AIDS Research Program: Optimizing Clinical HIV Genotypic Resistance Interpretation (2004 - 2006)

Unrestricted Gifts

Support HIVdbMake a Gift >>

Pharmaceutical Companies

  • Abbott Laboratories: 2000, 2002, 2004
  • Agouron Pfizer: 1998, 2000
  • Boehringer-Ingelheim: 2002, 2004
  • Bristol Myers Squibb: 2001, 2003, 2004, 2006, 2008
  • Dupont: 2001
  • Gilead Sciences: 1998, 2001, 2004, 2006, 2009
  • GlaxoSmithKline: 1999, 2000, 2002, 2003, 2006
  • Hoffman LaRoche: 1999, 2002, 2003, 2004, 2005, 2006
  • Idenix: 2004
  • Merck: 1998, 2000
  • Sequoia: 2006
  • Triangle: 2002

Diagnostic Companies

  • Applied Biosystems: 1998, 2000, 2001
  • Celera: 2003, 2005-2007, 2009, 2011, 2012, 2014
  • LabCorps: 2003
  • Quest Diagnostics: 1999
  • Roche Molecular: 1999, 2003, 2004, 2012
  • Siemens Health Care: 2009, 2012, 2014
  • Specialty Laboratories: 2000
  • SRA Life Sciences: 2000
  • Visible Genetics: 1999

Medical Education Companies

  • Academy of Continuing Education Programs: 2000
  • Clinical Care Options: 2005
  • Virology Networks: 1999, 2004

Non-Profit Organizations

  • CNYL Foundation: 2014
  • JM Kaplan Foundation: 2000